Enpresse
RxNorm Crosswalk NDC 21695-855

View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC

RxNorm Mapping Clinical Concepts

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The product Enpresse (NDC 21695-855) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 6 unique RxNorm concepts. By anchoring Rebel Distributors Corp's product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.

The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).

SCDPrescribable
Featured Concept

ethinyl estradiol 0.03 MG / levonorgestrel 0.05 MG Oral Tablet
(RxCUI 310230)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SCDPrescribable
Featured Concept

ethinyl estradiol 0.03 MG / levonorgestrel 0.125 MG Oral Tablet
(RxCUI 348804)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SCDPrescribable
Featured Concept

ethinyl estradiol 0.04 MG / levonorgestrel 0.075 MG Oral Tablet
(RxCUI 348805)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SCDPrescribable
Featured Concept

inert ingredients 1 MG Oral Tablet
(RxCUI 748797)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

Eth estra-Levonorgest 0.03-0.05 MG (6) Oral Tablet / Eth estra-Levonorgest 0.03-0.125 MG (10) Oral Tablet / Eth estra-Levonorgest 0.04-0.075 MG (5) Oral Tablet / Inert 1 MG (7) Oral Tablet 28 Day Pack
(RxCUI 748832)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

Enpresse 28 Day Triphasic Pack
(RxCUI 761977)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

Understanding RxNorm Mapping for Enpresse

RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 21695-855 to RxCUI 310230, 348804, 348805, 748797, 748832, 761977, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.

Term Type (TTY) Legend for This Page

The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:

  • PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
  • SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
  • SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
  • GPCK Generic Pack: A standardized concept for a clinical kit containing multiple generic components.
  • BPCK Branded Pack: A standardized concept for a clinical kit containing multiple branded components.

* Please review the full disclaimer at the bottom of this page.